News

Zuru's Diapers Under Scrutiny: Claims Challenged by NAD

Zuru's Diapers Under Scrutiny: Claims Challenged by NAD

National Advertising Division's Recommendations for Zuru Diapers

In recent developments, Zuru Edge Limited has been guided to alter or cease certain advertising claims regarding its Rascals and Millie Moon diaper products, following scrutiny from the National Advertising Division (NAD). This recommendation arose from a challenge initiated by Kimberly-Clark Corporation, the producer of Huggies diapers, aiming to ensure that advertising remains truthful and not misleading.

Zuru, a segment of the Zuru Group, competes in the diaper market with its Rascals and Millie Moon lines. The NAD investigated claims made about these products, including phrases such as “Our #1 Absorbing Diaper” and “World’s Softest Diaper,” as well as specific videographic demonstrations shared across social media platforms.

Examining the Claims: '5 Cups of Water' Demonstration

One of the most prominent claims dissected by the NAD involved the “5 Cups Water” demonstrations that appeared on platforms like TikTok, Instagram, and YouTube. These demonstrations showcased influencers, primarily mothers, showcasing the absorption capacity of Zuru diapers by pouring five cups of liquid over them. NAD determined that while the intention might have been to illustrate diaper absorbency, using water as a metric did not accurately represent real-life urine absorption, leading to an exaggerated portrayal of the product's performance.

The NAD emphasized that because these demonstrations connect to ordinary consumer expectations, they could mislead buyers into believing Zuru diapers can hold up to five cups of actual urine, a claim that was not backed by Zuru's testing. Consequently, the division advised that both the single and comparative “5 cups water” demonstrations, and the accompanying assertion “Holds up to 5 cups of water...unlike other diapers,” should be discarded.

Controversial Claims: Absorbency and Blowouts

Additionally, the claim “Our #1 Absorbing Diaper,” found on Rascals diaper packaging, prompted concern due to its misleading nature. The packaging included a clarification that the claim was in comparison to the Rascals product range; however, since Rascals produces only one diaper type, this comparison lacked merit. Moreover, Rascals and Millie Moon products are distinct and marketed separately, which only added to the confusion.

Furthermore, the claims “No Blowouts” and “Goodbye to Blowouts,” which arose in the same “5 Cups Water” demonstrations, imply a complete elimination of blowout incidents with Rascals diapers. The NAD identified that Zuru's testing did not sufficiently support this claim, leading to their recommendation for its discontinuation.

Claims of Superiority: The Softness Factor

Another significant point of contention was the assertion that Millie Moon is the “world’s softest diaper.” This claim emerged during product demonstrations as well as advertisements in blogs. Unfortunately, Zuru did not furnish any data comparing its products to those of other brands or evidence supporting its assertion. As a result, the NAD recommended that Zuru should refrain from using this claim moving forward.

Addressing Social Media Compliance

The NAD also scrutinized influencer marketing practices utilized by Zuru. They analyzed an influencer post documenting a receipt of a gift box from Rascals and concluded that the collaboration was not clearly disclosed. The division advised modifying the post to ensure transparency about the connection between the influencer and the brand.

Interestingly, during the questioning process, Zuru expressed their commitment to adapting their advertising to comply with the recommendations made by the NAD, despite expressing disagreement with some of the conclusions drawn. The acknowledgment indicates a willingness to prioritize responsible advertising practices.

The Role of BBB National Programs and NAD

BBB National Programs plays a pivotal role in facilitating independent industry self-regulation, thereby strengthening consumer trust in various businesses over the decades. The organization oversees multiple programs that resolve advertising disputes and promote accountability within industries, ensuring that marketing strategies align with ethical standards. Through these efforts, they aim to foster a fairer market landscape and elevate consumer experiences.

The National Advertising Division remains dedicated to safeguarding the integrity of advertising across the United States, reviewing claims across all media forms to implement consistent standards of truthfulness. Their decisions deliver essential protections to consumers and maintain an equitable environment for competing businesses.

Frequently Asked Questions

What claims did the National Advertising Division challenge?

The NAD challenged claims related to Zuru's “5 Cups Water” demonstrations, “Our #1 Absorbing Diaper,” “No Blowouts,” and “World’s Softest Diaper.”

Why were the '5 Cups Water' demonstrations deemed misleading?

The demonstrations exaggerated diaper absorbency as water does not realistically represent urine absorption, leading to potential consumer deception.

Is Zuru planning to change its advertising approach?

Yes, Zuru has expressed willingness to consider NAD's recommendations for future advertisements concerning their diaper products.

What is the role of BBB National Programs?

BBB National Programs is responsible for maintaining industry self-regulation, helping businesses adhere to ethical advertising practices and fostering consumer trust.

How can consumers stay informed about advertising standards?

Consumers can stay informed about advertising standards by following updates from the National Advertising Division and BBB National Programs, which publish decisions and guidelines regularly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 0

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

Updated Category News Views 4

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 24

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
Roadrunner's Bold Move: New LTL Service and Rate Hike

Updated Category News Views 3

When you shake up the status quo in logistics, you better be ready for the ride. Roadrunner Freight is doing just that with the launch of its first-ever outbound Canada-to-U.S. LTL service. They're shaking up a market that's been bogged down with inefficiencies for far too long. This isn't just another lane to add to a map; it's a new passage for Canadian goods, paving a...

Continue Reading
Invisors Expands PayBill Suite for Staffing Efficiency

Updated Category News Views 4

Invisors Doubles Down on Workday Integration The winds of change are whispering in the Professional & Business Services sector as Invisors rolls out its enhanced PayBill Suite. This move isn't just another tick on some corporate checklist; it's a serious play to streamline the gnarly process of transitions that staffing firms face. Invisors is tying this suite tightly...

Continue Reading
FP Movement Opens Energizing Boutique in Cranston, RI

Updated Category News Views 23

FP Movement Expands with Style in Rhode Island FP Movement is shaking things up in Cranston, Rhode Island, bringing its signature activewear vibe to Garden City Center with a new shop. It’s not just about buying leggings anymore; it’s about diving into a lifestyle that screams energy and community spirit. The store, which spans 1,209 selling-square-feet, opened its...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 23

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
JJ Lin's Iconic Singapore Grand Prix Show With 20 Songs

Updated Category News Views 3

Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 26

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
ASPR AI Unveils Private Sales Agent Studio

Updated Category News Views 11

Pushing Sales AI Into a Secure Future Picture a world where your most sensitive sales data stays safely behind your own digital doors. ASPR AI is shaking up the game by launching its Private Sales Agent Studio, a move that catapults enterprise sales management into a new era of control and customization. Why Private Means Business Here's the meat of it: sales AI usually...

Continue Reading

Top 5 Most Recently Viewed Articles

MediaAlpha Set for Q3 2024 Financial Results Presentation

Updated Category News Views 78

MediaAlpha's Upcoming Financial Report Announcement MediaAlpha, Inc. (NYSE: MAX), based in Los Angeles, has exciting news for its investors and stakeholders. The company is gearing up to announce its financial results for the third quarter of 2024 on an upcoming Wednesday. This announcement will take place after the market closes, providing important insights into the...

Continue Reading
Understanding Recent Trends in Canadian Stocks and Markets

Updated Category News Views 329

Canadian Stock Market Overview Recently, the Canadian stock market experienced a decline, reflecting a challenging trading environment. The decline was multifaceted, with notable tumbles in sectors such as the Consumer Staples, REITs, and Healthcare, which significantly influenced overall market performance. Investors and analysts are keenly observing these fluctuations,...

Continue Reading
Discover Key Trends in Network Observability for IT Success

Updated Category News Views 137

Emerging Trends in Network Observability Join experts as they discuss how IT leaders can adapt observability tools to meet modern network challenges. Enterprise Management Associates (EMA) is hosting an insightful webinar titled "Your NetOps Tools Are Aging Faster Than Your Network: 5 Emerging Trends That Are Reshaping Network Observability." Shamus McGillicuddy, Vice...

Continue Reading
Realbotix Secures Payment in Genesis Restructuring Efforts

Updated Category News Views 74

Realbotix Achieves Major Financial Recovery Realbotix Corp. (TSX-V: XBOT | Frankfurt Stock Exchange: 76M0.F | OTC: XBOTF) is making waves in the news by recently securing a significant cash payment of US$743,500 as part of its ongoing restructuring efforts with Genesis Global Capital. This milestone is a positive step for the Company as it works through the challenges of...

Continue Reading
Immedica Pharma's Loargys: Pioneering Hope in Rare Disease

Updated Category News Views 210

Game-Changing Approval or Just Another Hype Train? Time for a gut check: Immedica Pharma just made waves with its Loargys® (pegzilarginase-nbln), snagging accelerated FDA approval for treating hyperargininemia tied to Arginase 1 Deficiency (ARG1-D). So what's the big deal? Well, basically, we're talking about a breakthrough here—it's the first therapy proven to lower...

Continue Reading